PineBridge Investments’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-21,427
| Closed | -$1.16M | – | 840 |
|
|
2019
Q4 | $1.16M | Sell |
21,427
-16,661
| -44% | -$904K | 0.02% | 531 |
|
|
2019
Q3 | $1.99M | Buy |
38,088
+1,490
| +4% | +$69.4K | 0.03% | 401 |
|
|
2019
Q2 | $1.77M | Buy |
36,598
+6,595
| +22% | +$316K | 0.03% | 401 |
|
|
2019
Q1 | $1.52M | Buy |
30,003
+19,263
| +179% | +$1.14M | 0.03% | 417 |
|
|
2018
Q4 | $637K | Buy |
10,740
+1,593
| +17% | +$103K | 0.01% | 626 |
|
|
2018
Q3 | $603K | Buy |
9,147
+2,874
| +46% | +$168K | 0.01% | 703 |
|
|
2018
Q2 | $317K | Sell |
6,273
-203
| -3% | -$10.6K | 0.01% | 776 |
|
|
2018
Q1 | $341K | Sell |
6,476
-35,678
| -85% | -$1.78M | 0.01% | 761 |
|
|
2017
Q4 | $1.96M | Buy |
42,154
+10,460
| +33% | +$440K | 0.05% | 366 |
|
|
2017
Q3 | $1.28M | Sell |
31,694
-86
| -0.3% | -$3.11K | 0.03% | 464 |
|
|
2017
Q2 | $1.08M | Buy |
31,780
+27,268
| +604% | +$842K | 0.03% | 478 |
|
|
2017
Q1 | $131K | Buy |
4,512
+140
| +3% | +$4.26K | ﹤0.01% | 873 |
|
|
2016
Q4 | $144K | Hold |
4,372
| – | – | ﹤0.01% | 902 |
|
|
2016
Q3 | $138K | Buy |
4,372
+408
| +10% | +$11.9K | 0.01% | 656 |
|
|
2016
Q2 | $112K | Buy |
3,964
+202
| +5% | +$7.92K | 0.01% | 722 |
|
|
2016
Q1 | $137K | Sell |
3,762
-315
| -8% | -$11.1K | 0.01% | 614 |
|
|
2015
Q4 | $163K | Buy |
4,077
+292
| +8% | +$10.2K | 0.01% | 589 |
|
|
2015
Q3 | $108K | Buy |
3,785
+354
| +10% | +$11.7K | ﹤0.01% | 738 |
|
|
2015
Q2 | $113K | Sell |
3,431
-4,203
| -55% | -$130K | ﹤0.01% | 714 |
|
|
2015
Q1 | $219K | Buy |
7,634
+1,082
| +17% | +$31K | 0.01% | 710 |
|
|
2014
Q4 | $178K | Buy |
6,552
+281
| +4% | +$6.7K | 0.01% | 750 |
|
|
2014
Q3 | $133K | Buy |
6,271
+1,745
| +39% | +$40K | 0.01% | 778 |
|
|
2014
Q2 | $102K | Sell |
4,526
-2,792
| -38% | -$65K | ﹤0.01% | 772 |
|
|
2014
Q1 | $185K | Sell |
7,318
-329
| -4% | -$8.31K | 0.01% | 786 |
|
|
2013
Q4 | $176K | Buy |
7,647
+4,381
| +134% | +$91.3K | 0.01% | 824 |
|
|
2013
Q3 | $62K | Buy |
3,266
+388
| +13% | +$6.93K | ﹤0.01% | 871 |
|
|
2013
Q2 | $41K | Buy |
+2,878
| New | +$41.7K | ﹤0.01% | 970 |
|
Other funds holding EBS
SCM